These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 29809315)

  • 21. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
    Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFNL4 rs368234815 polymorphism does not predict risk of BK virus associated nephropathy after living-donor kidney transplant: A case-control study.
    Tanriver U; Emmerich F; Hummel JF; Jänigen B; Panning M; Arnold F; Tanriver Y
    Clin Transplant; 2022 Jul; 36(7):e14663. PubMed ID: 35368114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: A multicenter retrospective study.
    Keller N; Duquennoy S; Conrad A; Fafi-Kremer S; Morelon E; Bouvier N; Moulin B; Hurault De Ligny B; Caillard S
    Transpl Infect Dis; 2019 Apr; 21(2):e13058. PubMed ID: 30730102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2020 Mar; 35(3):375-382. PubMed ID: 30539254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of urinary decoy cells and associated risk factors in a Brazilian kidney, pancreas, and kidney-pancreas transplant population.
    Kroth LV; Henkin CS; Peres LD; Paganella MC; Mazzali M; Duval VD; Traesel MA; Saitovitch D
    Transplant Proc; 2012 Oct; 44(8):2394-6. PubMed ID: 23026603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preemptive reduction of immunosuppression upon high urinary polyomavirus loads improves patient survival without affecting kidney graft function.
    Broeders EN; Hamade A; El Mountahi F; Racapé J; Hougardy JM; Le Moine A; Vereerstraeten P
    Transpl Infect Dis; 2016 Dec; 18(6):872-880. PubMed ID: 27615506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.
    Gabardi S; Ramasamy S; Kim M; Klasek R; Carter D; Mackenzie MR; Chandraker A; Tan CS
    Transpl Infect Dis; 2015 Aug; 17(4):536-43. PubMed ID: 25989423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glomerular Parietal Epithelial Cells Infection Is Associated With Poor Graft Outcome in Kidney Transplant Recipients With BK Polyomavirus-Associated Nephropathy.
    Chen XT; Yang SC; Chen WF; Li J; Deng SX; Qiu J; Fei JG; Deng RH; Chen YY; Chen PS; Huang Y; Wang CX; Huang G
    J Infect Dis; 2019 May; 219(12):1879-1886. PubMed ID: 30649366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
    Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
    Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia.
    Knight RJ; Graviss EA; Nguyen DT; Kuten SA; Patel SJ; Gaber L; Gaber AO
    Clin Transplant; 2018 Jun; 32(6):e13265. PubMed ID: 29676018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-Frequency US for BK Polyomavirus-associated Nephropathy after Kidney Transplant.
    Yang D; Zhuang B; Wang Y; Huang G; Xu M; Lin M; Wang W; Huang G; Wang C; Xie X; Xie X
    Radiology; 2022 Aug; 304(2):333-341. PubMed ID: 35503018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.
    Elfadawy N; Flechner SM; Schold JD; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):553-61. PubMed ID: 24408118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.
    Pape L; Tönshoff B; Hirsch HH;
    Nephrol Dial Transplant; 2016 May; 31(5):842-7. PubMed ID: 26590390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivation.
    Korth J; Anastasiou OE; Bräsen JH; Brinkhoff A; Lehmann U; Kribben A; Dittmer U; Verheyen J; Wilde B; Ciesek S; Witzke O; Widera M
    J Clin Virol; 2019 Apr; 113():14-19. PubMed ID: 30771597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of HPyV9 and TSPyV coinfection on the development of BK polyomavirus viremia and associated nephropathy after kidney transplantation.
    van Rijn AL; Wunderink HF; de Brouwer CS; van der Meijden E; Rotmans JI; Feltkamp MCW
    J Med Virol; 2019 Jun; 91(6):1142-1147. PubMed ID: 30624811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced Risk of BK Polyomavirus Infection in HLA-B51-positive Kidney Transplant Recipients.
    Wunderink HF; Haasnoot GW; de Brouwer CS; van Zwet EW; Kroes ACM; de Fijter JW; Rotmans JI; Claas FHJ; Feltkamp MCW
    Transplantation; 2019 Mar; 103(3):604-612. PubMed ID: 30048396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BK virus-associated nephropathy in sirolimus-treated renal transplant patients: incidence, course, and clinical outcomes.
    Benavides CA; Pollard VB; Mauiyyedi S; Podder H; Knight R; Kahan BD
    Transplantation; 2007 Jul; 84(1):83-8. PubMed ID: 17627242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polyoma BK virus reactivation in kidney and pancreas-kidney recipients.
    Matłosz B; Durlik M; Wesołowska A; Mróz A; Zegarska J; Rowiński W; Szmidt J
    Transplant Proc; 2005 Mar; 37(2):947-8. PubMed ID: 15848584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study.
    Ji J; Feng S; Jiang Y; Wang W; Zhang X
    Exp Clin Transplant; 2019 Dec; 17(6):727-731. PubMed ID: 30995893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BK polyomavirus nephropathy in two kidney transplant patients with distinct diagnostic strategies for BK virus and similar clinical outcomes: two case reports.
    Gouvêa ALF; Cosendey RIJ; Nascimento ALR; Carvalho FR; Silva AA; de Moraes HP; Rochael MC; Varella RB; Almeida SG; Almeida JR; Lugon JR
    J Med Case Rep; 2017 May; 11(1):146. PubMed ID: 28535782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.